Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
8,915,338
-
Share change
-
+329,422
-
Total reported value
-
$122,684,000
-
Price per share
-
$13.76
-
Number of holders
-
59
-
Value change
-
+$7,942,834
-
Number of buys
-
29
-
Number of sells
-
29
Institutional Holders of EIDOS THERAPEUTICS INC - COM (EIDX) as of Q4 2018
As of 31 Dec 2018,
EIDOS THERAPEUTICS INC - COM (EIDX) was held by
59 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,915,338 shares.
The largest 10 holders included
Viking Global Investors LP, BlackRock Inc., Aisling Capital Management LP, Redmile Group, LLC, PERCEPTIVE ADVISORS LLC, Foresite Capital Management IV, LLC, Cormorant Asset Management, LP, Board of Trustees of The Leland Stanford Junior University, Vanguard Group Inc, and AMERICAN INTERNATIONAL GROUP INC.
This page lists
59
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.